Skip to main content
logo
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
13.39
+0.84 (6.69%)
At close: Apr 20, 2026, 4:00 PM EDT
13.51
+0.12 (0.90%)
After-hours: Apr 20, 2026, 7:23 PM EDT

Artiva Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.2533.494.932
Revenue Growth (YoY)
--99.25%579.21%146.30%-
Gross Profit
-0.2533.494.932
Selling, General & Admin
20.2717.2113.9120.7812.86
Research & Development
69.5450.3350.2543.9842.41
Total Operating Expenses
89.8167.5364.1664.7655.27
Operating Income
-89.81-67.28-30.67-59.83-53.27
Interest Income
5.965.352.541.29-
Other Non-Operating Income (Expense)
-0.01-3.44-0.51-0.218.55
Total Non-Operating Income (Expense)
5.951.912.021.0918.55
Pretax Income
-83.87-65.37-28.65-58.74-34.72
Provision for Income Taxes
---0.07-0.05-
Net Income
-83.87-65.37-28.72-58.79-34.72
Net Income to Common
-83.87-65.37-28.72-58.79-34.72
Shares Outstanding (Basic)
241111686
Shares Outstanding (Diluted)
241111686
Shares Change (YoY)
117.11%1302.55%4.70%-99.89%8.60%
EPS (Basic)
-3.43-5.81-35.7876.67-104.74
EPS (Diluted)
-3.43-5.81-35.7876.67-104.74
Shares Outstanding
24.624.29---
Free Cash Flow
-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Per Share
-3.25-4.94-63.14-74.51-0.02
Gross Margin
-100.00%100.00%100.00%100.00%
Operating Margin
--26805.60%-91.58%-1213.32%-2660.94%
Profit Margin
--26045.00%-85.75%-1192.21%-1734.22%
FCF Margin
--22180.90%-151.34%-1158.55%-850.55%
EBITDA
-87.21-64.85-28.41-58.67-53.02
EBITDA Margin
--25837.10%-84.81%-1189.84%-2648.55%
EBIT
-89.81-67.28-30.67-59.83-53.27
EBIT Margin
--26805.60%-91.58%-1213.32%-2660.94%
Effective Tax Rate
0.00%0.00%0.25%0.09%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q